Intersect ENT, Inc. provided revenue guidance for the third and fourth quarter of 2020. For the third quarter, Net sales are expected to be in the range of $22.4 to $22.8 million. Based on current elective procedure volumes and referral trends, the Company expects fourth quarter revenue to be 85% to 90% of fourth quarter 2019 revenues. The Company believes this progress will position it to grow revenues in 2021 relative to 2019.